In summary, our results disclose a novel mechanism for eIF4A3 to unwind secondary structure in 5′ UTRs of mRNAs, which is significant for identifying new therapeutic target by interfering with mRNA initial translation in ESCC. This evidence concerns the gene EIF4A3 and esophageal squamous cell carcinoma.